Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis

30 Mar 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Eosinophilic Disorders and Syndromes
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16572198
DOI: 10.1038/sj.leu.2404209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresisPMID 16572198Read ↗

[A quantitative assay for JAK2 mutation in 135 patients with chronic myeloproliferative neoplasms].Semantic proximity Read ↗

Laboratory detection of JAK2V617F in human myeloproliferative neoplasms.Semantic proximity Read ↗

Quantitative assay for Janus kinase 2 (JAK2) mutation in Chinese patients with chronic myeloproliferative disorders.Semantic proximity Read ↗

[The quantitative assay and clinical significance of JAK2V617F mutation in 131 patients with chronic myeloproliferative disorders].Semantic proximity Read ↗

Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasmsSemantic proximity Read ↗

Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disordersSemantic proximity Read ↗

Comparative evaluation of three JAK2V617F mutation detection methods.Semantic proximity Read ↗

Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis.Semantic proximity Read ↗

Detection Mutations of JAK2 exon 12 in Patients with JAK2 (V617F)-negative Myeloproliferative Disorders.Semantic proximity Read ↗

Clinical Performance of <i>JAK2</i> V617F Mutation Detection Assays in a Molecular Diagnostics LaboratorySemantic proximity Read ↗

Development of an in-house real time q-PCR assay for the detection of jak2 mutations in myeloproliferative neoplasmsSemantic proximity Read ↗

Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.